Filing Details
- Accession Number:
- 0001645627-17-000073
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-02 13:16:35
- Reporting Period:
- 2017-05-31
- Filing Date:
- 2017-06-02
- Accepted Time:
- 2017-06-02 13:16:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.07 | 21,028,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.07 | 21,029,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.07 | 21,030,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.07 | 21,031,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.07 | 21,032,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.07 | 21,033,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.07 | 21,034,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.06 | 21,035,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.06 | 21,036,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.06 | 21,037,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.06 | 21,038,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.06 | 31,039,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.06 | 21,040,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.06 | 21,041,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-31 | 1,000 | $0.06 | 21,042,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.05 | 21,043,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.05 | 21,044,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.05 | 21,045,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.05 | 21,046,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.06 | 21,047,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.06 | 21,048,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.06 | 21,049,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.06 | 21,050,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.06 | 21,051,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.06 | 21,052,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.06 | 21,053,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.06 | 21,054,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.06 | 21,055,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 1,000 | $0.06 | 21,056,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 50 | $0.06 | 21,056,299 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
